Transition Document for the United States Patent and Trademark Office
Summary
This transition document provides over 25 actionable recommendations on the future of the United States Patent and Trademark Office (USPTO), in order to support future federal leadership and enable their success. The document is the result of collaboration between the Day One Project and a group of veteran policymakers who convened virtually to produce recommendations related to the following three categories:
- Identifying specific policy and governance ideas that can be pursued in the first days and months of the next administration.
- Gathering “lessons learned” from those who have previously served in government to learn from past challenges and better inform future initiatives.
- Understanding key science and technology staffing and “talent” needs, and related challenges for the USPTO that can be addressed in the next administration.
The document also includes a cover memo which highlights some of the overarching key considerations for the future of the USPTO.
Contributors
- Margo A. Bagley
- Sharon Barner
- Brian Cassidy
- Colleen V. Chien
- Mark Allen Cohen
- Ayala Deutsch
- Ben Haber
- Philip G. Hampton
- Justin Hughes
- David J. Kappos
- Quentin Palfrey
- Arti K. Rai
- Teresa Stanek Rea
- Robert L. Stoll
- A. Christal Sheppard
- Saurabh Vishnubhakat
- Stephen Yelderman
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.
The Federation of American Scientists supports the National Security Commission on Emerging Biotechnology’s Final Report and the Recommendations contained within it.
The U.S. should create a new non-governmental Innovation Accelerator modeled after the successful In-Q-Tel program to invest in small and mid-cap companies creating technologies that address critical needs of the United States.